RBM15は,TMC5のm6A変異を調節することによって,COADの進行を促進する

Errong Tian¹, Li Gao¹, Lan Wu¹

¹Department of Pain, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010010, Inner Mongolia, China.

Hereditas

|August 29, 2025

まとめ

細胞増殖,移動,侵入を強めることで結腸腺がん (COAD) の進行を促進する. RNA結合モチーフタンパク質-15 (RBM15) はTMC5 mRNAを安定させ,COADの潜在的な治療標的となる.

科学分野:

腫瘍学
分子生物学
癌研究

背景:

大腸腺がん (COAD) は,高い死亡率と悪い予後のために重大な健康上の課題を提示します.
トランスメブランチャネル型5 (TMC5) の腫瘍性作用は,様々ながんにおいて確立されていますが,COADにおけるその特定の機能は未知のままです.

研究の目的:

大腸腺がんの発生と進行におけるTMC5の役割と基礎となる分子メカニズムを解明する.
COADにおけるTMC5とRNA結合モチーフタンパク質-15 (RBM15) の関係を調査する.

主な方法:

TIMERとUALCANのデータベースを用いた遺伝子発現分析
ウェスタン・ブロットとRT-qPCRによるタンパク質とmRNAレベル評価
インビトロ機能検査 (増殖,アポトーシス,移住,侵入) とインビボ異種移植モデル.
m6A改変,MeRIP,二重ルシフェラーゼレポーター試験を含む分子機構の調査.

主要な成果:

TMC5とRBM15の発現は,COADの組織と細胞で著しく上昇しています.
TMC5の阻害は,COAD細胞の増殖,移動,侵入,上皮-メゼンキマ移行 (EMT),および糖分解を抑制し,同時にアポトーシスおよびフェロプトーシスを誘導した.
RBM15は,m6A変異によってmRNAの安定性を調節し,COADの進行を促すことで,TMC5の発現を強化する.

結論:

RBM15によるTMC5 mRNAの安定化は,COADにおける悪性行動を引き起こします.
TMC5とRBM15を含むその調節経路は,大腸腺がんの治療において有望な治療目標です.

キーワード:

COAD についてフェロプトーシス核拡散 RBM15 について TMC5 について

さらに関連する動画

08:50

Methylated RNA Immunoprecipitation Assay to Study m5C Modification in Arabidopsis

Published on: May 14, 2020

6.8K

17:12

Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS

Published on: December 20, 2010

15.7K

関連する概念動画

03:03

mTOR Signaling and Cancer Progression

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

3.9K

02:23

Abnormal Proliferation

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

4.6K

02:07

Tumor Progression

6.5K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

6.5K

02:23

Master Transcription Regulators

7.0K

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...

7.0K

01:22

MicroRNAs

3.1K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...